AstraZeneca PLC
1453.50
23-December-24 08:25:00
15 minutes delayed
Stocks
+24.50
+1.71%
Today's range
1437.00 - 1454.50
ISIN
N/A
Source
Cboe
-
22 Dec 2024 05:16:51 By NASDAQ US Markets
-
3 Unstoppable Stocks to Buy Right Now
15 Dec 2024 05:33:05 By NASDAQ US Markets
-
March 2025 Options Now Available For AstraZeneca (AZN)
06 Dec 2024 10:01:12 By NASDAQ US Markets
-
AZN : TROPION Analysis Reveals Datopotamab Deruxtecan Efficacy In Advanced EGFR-Mutated Lung Cancer
05 Dec 2024 21:31:29 By NASDAQ US Markets
-
FDA Approves AstraZeneca's Imfinzi For Limited-Stage Small Cell Lung Cancer
04 Dec 2024 20:59:20 By NASDAQ US Markets
-
AstraZeneca Names A MSK Leader To Global Cancer Post
25 Nov 2024 10:17:34 By Forbes - World
-
Lunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology Solutions
18 Nov 2024 12:17:39 By NASDAQ US Markets
-
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
14 Nov 2024 06:43:11 By NASDAQ US Markets
-
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript
12 Nov 2024 16:04:51 By NASDAQ US Markets
-
AstraZeneca Q3 Net Income Rises; Upgrades 2024 Guidance
12 Nov 2024 02:02:49 By NASDAQ US Markets
-
AstraZeneca To Invest $3.5 Bln In US To Expand R&D And Manufacturing
12 Nov 2024 02:02:49 By NASDAQ US Markets
-
AstraZeneca : Wainzua Recommended By CHMP For EU Approval In Hereditary Transthyretin Amyloidosis
21 Oct 2024 02:00:49 By NASDAQ US Markets
-
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
08 Oct 2024 13:20:34 By NASDAQ Stocks
-
Arcus Announces Clinical Trial Collaboration With AstraZeneca To Evaluate Casdatifan
02 Oct 2024 16:15:33 By NASDAQ US Markets
-
AstraZeneca Becomes Oversold (AZN)
24 Sep 2024 17:47:41 By NASDAQ US Markets
-
AstraZeneca Becomes Oversold (AZN)
24 Sep 2024 17:45:01 By NASDAQ Stocks
-
CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease
24 Sep 2024 12:14:18 By NASDAQ Stocks
-
AstraZeneca: TROPION-Breast01 Phase III Trial Fails To Achieve Statistical Significance
23 Sep 2024 02:29:23 By NASDAQ US Markets
-
AZN : IMFINZI Regimen Reduces Death Risk By 25% In Late-Stage Muscle-Invasive Bladder Cancer Trial
15 Sep 2024 12:57:59 By NASDAQ US Markets
-
SOPHiA Genetics, AstraZeneca Team Up To Expand Liquid Biopsy Testing To 20 New Locations Globally
10 Sep 2024 10:30:45 By NASDAQ US Markets
- <<
- <
- 1
- >